We demonstrated that PCB pretreatment before t-PA administration significantly reduced BBB damage and brain edema and infarction, improved the short-term and long-term behavioral outcomes, and increased survival following 6 hr ischemia, which is beyond the standard 4.5 hr t-PA therapeutic time window. The gene discussed is PLAT; the disease is ischemia.